A study points to new therapeutic targets for tumors associated with chronic inflammation

(Institute for Research in Biomedicine (IRB Barcelona)) Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets. The study has been published in the journal EMBO Molecular Medicine.